“Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway” (2025) Biomolecules and Biomedicine, 25(9), pp. 2004–2019. doi:10.17305/bb.2025.11546.